FertilityAssist 2

About 70% of couples who complete treatment eventually succeed in conceiving a child1.

While many women experience success with their first treatment cycle, some women require a second cycle before achieving their goal.

You will need Adobe Flash Player to view this content.

  • The FertilityAssist2 program from Fertility LifeLines™ helped Lindsay afford treatment.

Enrollment is easy

Just ask your healthcare provider to enroll you and fill your Gonal-f® prescription through Freedom Fertility Pharmacy™.

For more information about FertilityAssist 2, call Fertility LifeLines™ at 1-866-LETS-TRY or download the FertilityAssist 2 Program Overview.

FertilityAssist 2 FAQs

What is FertilityAssist 2?

FertiltyAssist 2 is a program designed to help cash-paying patients who may require a second fertility treatment cycle. FertilityAssist 2 can make your treatment more affordable with savings of up to $500* on Gonal-f® (follitropin alfa for injection) when you fill your prescriptions through Freedom Fertility Pharmacy™.

Here is how it works:

Chart showing savings per cycle

How do I enroll in FertilityAssist 2?

Ask your healthcare provider to enroll you and fill your Gonal-f® prescription through Freedom Fertility Pharmacy™. Or download the FertilityAssist 2 Program Overview.

How can I learn more about Gonal-f® and FertiltyAssist 2?

Talk to your doctor to learn more about Gonal-f®.

If you have additional questions about FertilityAssist 2, you can speak to a representative at Fertility LifeLines™ at 1-866-LETS-TRY (1-866-538-7879). We're here to help!

Important eligibility information

Fill your cash prescription for Gonal-f® through Freedom Fertility Pharmacy™ for two cycles of treatment.

  • First cycle must contain a minimum of 900 IU
  • Second cycle must contain a minimum of 900 IU for a cash savings of $250 or a minimum of 2100 IU for a cash savings of $500
  • Enroll in FertilityAssist 2 between December 1, 2008 and June 30, 2010
  • Second prescription must be received and shipped by Freedom Fertility Pharmacy™ on or before September 30, 2010
  • Only one card may be redeemed at a time and cannot be used in conjunction with any other offer or discount program
  • 1. Corson SL. Conquering Infertility—A Guide for Couples. 4th ed. Edmonton, Alberta, Canada: EMIS Canada Inc; 1999.

EMD Serono reserves the right to modify or cancel the FertilityAssist 2 program at any time.

Get a Snapshot of Your Unique Fertility Situation.

Register for My Fertility LifeLines™ today and get a customized report about your fertility with our Fertility Assessment Tool.

Gonal-f® Has Helped Many Couples.

Learn more about this fertility medication.

Personal Stories

Watch videos

Hear from others who have gone through what you and your partner may be experiencing.
Watch videos

FIND A FERTILITY SPECIALIST

Enter your Zip code to find a fertility treatment specialist or fertility clinic in your area:

Important Considerations:
Gonal-f® RFF Pen (follitropin alfa injection) is indicated for the induction of ovulation and pregnancy in the oligo-anovulatory infertile patient in whom the cause of infertility is functional and not due to primary ovarian failure. Gonal-f® RFF Pen is also indicated for the development of multiple follicles in the ovulatory patient participating in an Assisted Reproductive Technology (ART) program. Gonal-f® RFF Pen (follitropin alfa injection) should only be prescribed by physicians specializing in fertility or reproductive health. Gonal-f® is a potent gonadotropic substance capable of causing mild to severe adverse reactions, including Ovarian Hyperstimulation Syndrome (OHSS) in women with or without pulmonary or vascular complications, and multiple births. Gonal-f® is contraindicated in women who exhibit prior hypersensitivity to FSH preparations, primary gonadal failure, uncontrolled thyroid or adrenal dysfunction and pregnancy. Nursing women should not use Gonal-f®. Common side effects include headache, abdominal pain, enlarged abdomen, and injection site disorders. For complete product details, see full prescribing information.

Important Considerations:
Women: Gonal-f® (follitropin alfa for injection) is indicated for the induction of ovulation and pregnancy in the anovulatory infertile patient in whom the cause of infertility is functional and not due to primary ovarian failure. Gonal-f® is also indicated for the development of multiple follicles in the ovulatory patient participating in an Assisted Reproductive Technology (ART) program.
Men: Gonal-f® (follitropin alfa for injection) is indicated for the induction of spermatogenesis in men with primary and secondary hypogonadotropic hypogonadism in whom the cause of infertility is not due to primary testicular failure. Gonal-f® (follitropin alfa for injection) should only be prescribed by physicians who are thoroughly familiar with infertility problems and their management. Gonal-f® is a potent gonadotropic substance capable of causing Ovarian Hyperstimulation Syndrome (OHSS) in women with or without pulmonary or vascular complications. Gonal-f® is contraindicated in women and men who exhibit prior hypersensitivity to recombinant FSH preparations or one of their excipients, high levels of FSH indicating primary gonadal failure, uncontrolled thyroid or adrenal dysfunction, sex hormone dependent tumors of the reproductive tract and accessory organs, and an organic intracranial lesion such as a pituitary tumor; and in women who exhibit abnormal uterine bleeding of undetermined origin, ovarian cyst or enlargement of undetermined origin and pregnancy. Women who are pregnant or nursing should not use Gonal-f®. The most common side effects in patients using Gonal-f® include headache, ovarian cysts, nausea and upper respiratory infections in women and in men, acne, breast pain and growth, and fatigue. Injection site reactions were also reported. Reports of multiple births have been associated with Gonal-f® treatment. For complete product details, see the full prescribing information.

For complete product details, please read the Prescribing Information offered below.


© EMD Serono, Inc. CIM Last Update 2008-09-16
This site contains medical information that is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.

This site contains information that is intended for US residents only. Canadian residents should consult the EMD Serono Canada Inc. Web site at www.emdserono.ca for information on products and services approved in Canada.

EMD Serono

Close

Please wait... loading

View the Full Glossary